WS
LJPC

Wedbush Securities’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Wedbush Securities’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,000
Closed -$64K – 1058
2020
Q2 		$64K Buy
+15,000
New +$91.3K 0.01% 890

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wedbush Securities's LJPC Position: Q3 2020 in Review

Wedbush Securities sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 15,000 shares — an estimated $64K sold.

Wedbush Securities first reported a position in LJPC in Q2 2020 and held it in 1 quarter. The position peaked at $64K in Q2 2020. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • Wedbush Securities reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • Wedbush Securities sold 15,000 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $64K.
  • Wedbush Securities first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 1 quarter.
  • Wedbush Securities's La Jolla Pharmaceutical Company position peaked at $64K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.